IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,821,558 | -9.5% | 500,681 | -0.0% | 0.02% | -7.4% |
| Q2 2023 | $5,328,693 | +2.8% | 500,817 | +1.7% | 0.03% | -3.6% |
| Q1 2023 | $5,181,352 | +38.2% | 492,524 | +62.8% | 0.03% | +27.3% |
| Q4 2022 | $3,748,780 | +637.9% | 302,565 | +411.3% | 0.02% | +633.3% |
| Q3 2019 | $508,000 | +8.5% | 59,175 | +46.5% | 0.00% | -25.0% |
| Q4 2015 | $468,000 | +14.7% | 40,400 | +3.1% | 0.00% | +33.3% |
| Q3 2015 | $408,000 | – | 39,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |